13F-HR filed by AIHC Capital Management Ltd
AIHC Capital Management Ltd filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 14:59:20 UTC, with 6 holding rows worth $108,685,317.
- Accession
- 0001172661-26-005109
- Filer
- CIK 2103725
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 6 entries on the cover page, a total value of $108,685,317 stated on the cover page (in dollars after the unit check, H1), rows summing to $108,685,317 with VALUE read as dollars as filed, 13F file number 028-26081. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 4,630,986 | $62,379,381 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,182,389 | $23,517,717 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 83,133 | $17,063,880 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 2,878,033 | $3,928,515 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 139,673 | $1,495,898 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 30,265 | $299,926 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-005109 | this filing | 2026-11-16 |